已收盤 02-06 16:00:00 美东时间
+0.065
+0.86%
今日重点评级关注:Piper Sandler:上调Korro Bio评级至"超配",目标价从11美元升至30美元;Piper Sandler:维持Nurix Therapeutics"超配"评级,目标价从32美元升至35美元
01-30 17:38
Keefe, Bruyette & Woods analyst Damon Delmonte maintains Capitol Federal Finl (NASDAQ:CFFN) with a Market Perform and raises the price target from $6.5 to $7.5.
01-30 00:44
Capitol Federal Finl (NASDAQ:CFFN) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.14 by 14.29 percent. This is a 33.33 percent increase over earnings of $0.12 per share
01-28 22:02
Options markets are pricing in post-earnings swings of up to 50% this week, with regional banks in focus and the Fed decision set to amplify volatility.
01-27 03:47
Capitol Federal Financial, Inc. (NASDAQ:CFFN) (the "Company") announced today that its Board of Directors has declared a special cash dividend of $0.04 per share on outstanding CFFN common stock.The dividend is payable
2025-12-18 02:05
Capitol Federal Finl (NASDAQ:CFFN) reported quarterly earnings of $0.14 per share which met the analyst consensus estimate. This is a 55.56 percent increase over earnings of $0.09 per share from the same period last
2025-10-29 21:03
Capitol Federal Financial (NASDAQ:CFFN) declares $0.085/share quarterly dividend, in line with previous. Forward yield 5.44% Payable Nov. 21; for shareholders of record Nov. 7; ex-div Nov. 7. See CFFN...
2025-10-29 04:58
今日重点评级关注:Canaccord Genuity:维持ATAI Life Sciences"买入"评级,目标价从11美元升至14美元;麦格理:维持Cleanspark"跑赢大市"评级,目标价从20美元升至30美元
2025-10-23 10:06
Piper Sandler analyst Justin Crowley assumes Capitol Federal Finl (NASDAQ:CFFN) with a Neutral rating and announces Price Target of $7.
2025-10-22 23:32
Capitol Federal Financial ( ($CFFN) ) has issued an update. Capitol Federal Fin...
2025-10-18 00:28